Careers

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2025 HSCA National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Congressional Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2025 HSCA National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Congressional Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HSCA Applauds House Judiciary Committee for Advancing the CREATES Act

April 30, 2019 by Elizabeth Landau Congressional Comments and Responses 0 comments

Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO
Khatereh Calleja today released the following statement applauding the House Judiciary Committee
members for voting to advance the CREATES Act (H.R. 965):

“The Healthcare Supply Chain Association (HSCA) and its member group purchasing organizations
(GPOs) applaud Chairman Nadler, Ranking Member Collins, and the members of the House Judiciary
Committee for helping to increase competition in the generic drug marketplace by voting to advance the
CREATES Act. Americans rely on generic drugs to reduce costs and increase access to necessary
medication, and price spikes for commonly used drugs jeopardize patient access to care. HSCA supports
policy solutions like the CREATES Act that lower drug prices, encourage competition and innovation in
the marketplace, and end anti-competitive abuses utilized by some brand-name manufacturers. We
urge the House to quickly pass the CREATES Act to protect patient access to essential medications.”

 

Read the full statement here.

Prev
Next

Related Posts

HSCA Applauds House Judiciary Committee for Advancing the CREATES Act
April 30, 2019

Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
October 30, 2019

Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more
Joint Letter of Support for the MEDS Act
November 5, 2019

Dear Senator Collins and Senator Smith, The undersigned organizations are...

Learn more
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
March 3, 2020

Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA)...

Learn more

Our Office

Healthcare Supply Chain Association
750 9th Street NW, Suite 650
Washington, DC 20001

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Response to the U.S. Department of Commerce’s Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
    May 8, 2025
  • HSCA Response to the U.S. Trade Representative’s Request for Comments on Unfair and Non-Reciprocal Foreign Trade Practices
    March 12, 2025